Bentham Science Logo

Clinical Cancer Drugs

Volume 6, 2 Issues, 2019
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access

Contents

Clinical Cancer Drugs, Volume 4 - Number 1


Review Article

MicroRNA: A Multi-Facet Biological Target for Cancer and Other Diseases

, 4(1): 2 - 9

Mahima Kaushik, Swati Chaudhary, Swati Mahendru, Saami Ahmed, Ankit Kumar Pathak and Shrikant Kukreti


DOI: 10.2174/2212697X04666170123122037



Review Article

Nitrogen Mustards: The Novel DNA Alkylator

, 4(1): 10 - 46

Bhabesh Chandra Deka and Pradip Kr. Bhattacharyya


DOI: 10.2174/2212697X04666170123120528



Review Article

The PI3K/AKT/mTOR-Signal Transduction Pathway as Drug Target in Triple-Negative Breast Cancer

, 4(1): 47 - 58

Jens C. Hahne, Jorg B. Engel, Arnd Honig, Susanne R. Meyer, Domenico Zito, Andrea Lampis and Nicola Valeri


DOI: 10.2174/2212697X04666170321112629



Review Article

Dexamethasone for the Prevention of Cisplatin-induced Ototoxicity

, 4(1): 59 - 64

Ashley R. Popay, Daniel R. Lloyd, Mark N. Wass and Martin Michaelis


DOI: 10.2174/2212697X04666170331171359



Case Studies

Meningioma in an Elderly Presenting as Psychosis: A Case Report

, 4(1): 65 - 68

Deepak Moyal and Amit Garg


DOI: 10.2174/2212697X04666170331170942



Research Article

Prevalence of Neuropathy Associated With Bortezomib: A Retrospective Study

, 4(1): 69 - 72

Pulivarthi Swaroopa, Mathew Josy, Ehresmann Kirsten and Gurram Murali Krishna


DOI: 10.2174/2212697X03666161128102453





Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
USA

Biography View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.
Track Your Manuscript:


Related Journals

Related eBooks

eBooks Catalog